Good Health Can’t Wait.

Statutory Reports • Board’s Report
Annual Report 2014 - 15
PART “B”: ASSOCIATES AND JOINT VENTURES
SL. NO.
NAME OF THE
ASSOCIATES AND
JOINT VENTURES
LATEST AUDITED
BALANCE SHEET DATE
SHARES OF ASSOCIATE/
JOINT VENTURES HELD BY THE
COMPANY ON THE YEAR END
NO.
AMOUNT OF
INVESTMENT IN
ASSOCIATES/
JOINT VENTURE
EXTEND OF
HOLDING %
NET WORTH
ATTRIBUTABLE TO
SHAREHOLDING AS
PER LATEST AUDITED
BALANCE SHEET
PROFIT/LOSS
FOR THE
YEAR
CONSIDERED IN
CONSOLIDATION
NOT
CONSIDERED IN
CONSOLIDATION
DESCRIPTION OF HOW
THERE IS A SIGNIFICANT
INFLUENCE
REASON WHY THE
ASSOCIATE/JOINT
VENTURE IS NOT
CONSOLIDATED
1 DRANU LLC, USA NA NA 360 50% 43 (125) – NA NA
2 DRSS Solar Power Private Limited, India (1) 31.03.2015 26,000 – 26% – – – NA NA
(1)
DRSS Solar Power Private Limited, India is yet to commence operations.
for and on behalf of the Board of Directors of Dr. Reddy’s Laboratories Limited
K Satish Reddy
Chairman
G V Prasad
Co-Chairman & Chief Executive Officer
Place Hyderabad Saumen Chakraborty President & Chief Financial Officer
Date 12 May 2015 Sandeep Poddar Company Secretary
ANNEXURE - II
FORM NO. AOC–2
(Pursuant to clause (h) of sub-section (3) of Section 134 of the Act and Rule 8(2) of the Companies (Accounts) Rules, 2014)
Form for disclosure of particulars of contracts/arrangements entered into by the company with related parties referred to in
sub-section (1) of Section 188 of the Companies Act, 2013 including certain arm’s length transactions under third proviso thereto
Details of contracts or arrangements or transactions not at arm’s length basis : None
(a)
(b)
(c)
(d)
(e)
(f)
(g)
(h)
Name(s) of the related party and nature of relationship
Nature of contracts/arrangements/transactions
Duration of the contracts/arrangements/transactions
Salient terms of the contracts or arrangements or transactions including the value,
if any
Justification for entering into such contracts or arrangements or transactions
Date(s) of approval by the Board
Amount paid as advances, if any
Date on which the special resolution was passed in general meeting as required
under first proviso to Section 188
Not Applicable
Details of material contracts or arrangement or transactions at arm’s length basis
(a) Names(s) of the related party and nature of relationship Dr. Reddy’s Laboratories Inc., USA- Wholly-owned subsidiary
(b) Nature of contracts/arrangements/transactions Transfer or receipt of products, goods, materials or services.
(c) Duration of the contracts/arrangements transactions Ongoing.
(d) Salient terms of the contracts or arrangements or transactions including the value,
if any:
Transfer or receipt of products, goods, materials or services on arm’s
length for an estimated amount of up to US$ 1,100 million every
financial year.
(e) Date(s) of approval by the Board, if any 13 May 2014
(f) Amount paid as advances, if any –
K Satish Reddy
Chairman
91